Penault Llorca F - Search Results

1

Resistance to human epidermal growth factor receptor type 2-targeted therapies.

Thery JC, Spano JP, Azria D, Raymond E, Penault Llorca F. Thery JC, et al. Among authors: penault llorca f. Eur J Cancer. 2014 Mar;50(5):892-901. doi: 10.1016/j.ejca.2014.01.003. Epub 2014 Jan 22. Eur J Cancer. 2014. PMID: 24462377 Review.

2

Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients.

Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, Mignotte H, Fichet V, Fay R, Servent V, Giard S, Charra-Brunaud C, Auvray H, Penault-Llorca F, Charpentier JC. Cutuli B, et al. Among authors: penault llorca f. Eur J Cancer. 2001 Dec;37(18):2365-72. doi: 10.1016/s0959-8049(01)00303-3. Eur J Cancer. 2001. PMID: 11720829

3

Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer.

Chollet P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F. Chollet P, et al. Among authors: penault llorca f. Br J Cancer. 2002 Apr 8;86(7):1041-6. doi: 10.1038/sj.bjc.6600210. Br J Cancer. 2002. PMID: 11953845 Free PMC article.

4

[Principal therapeutic uses of monoclonal antibodies in oncology].

Penault-Llorca F, Etessami A, Bourhis J. Penault-Llorca F, et al. Cancer Radiother. 2002 Nov;6 Suppl 1:24s-28s. doi: 10.1016/s1278-3218(02)00218-4. Cancer Radiother. 2002. PMID: 12587379 Review. French.

5

[Prognostic value of epidermal growth factor receptor].

Penault-Llorca F, Durando X, Bay JO. Penault-Llorca F, et al. Bull Cancer. 2003 Nov;90 Spec No:S192-6. Bull Cancer. 2003. PMID: 14763139 Review. French.

6

Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray.

Bibeau F, Boissière-Michot F, Sabourin JC, Gourgou-Bourgade S, Radal M, Penault-Llorca F, Rochaix P, Arnould L, Bralet MP, Azria D, Ychou M. Bibeau F, et al. Among authors: penault llorca f. Virchows Arch. 2006 Sep;449(3):281-7. doi: 10.1007/s00428-006-0247-9. Epub 2006 Jul 25. Virchows Arch. 2006. PMID: 16865406 Free PMC article.

7

High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study.

Lacroix-Triki M, Mathoulin-Pelissier S, Ghnassia JP, Macgrogan G, Vincent-Salomon A, Brouste V, Mathieu MC, Roger P, Bibeau F, Jacquemier J, Penault-Llorca F, Arnould L. Lacroix-Triki M, et al. Among authors: penault llorca f. Eur J Cancer. 2006 Nov;42(17):2946-53. doi: 10.1016/j.ejca.2006.06.020. Epub 2006 Sep 20. Eur J Cancer. 2006. PMID: 16989997

8

[Targeted therapies: the question of target detection and evaluation].

Penault-Llorca F. Penault-Llorca F. Bull Cancer. 2007;94(7 Suppl):F245-8. Bull Cancer. 2007. PMID: 17965004 Review. French.

9

Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition.

Bozec A, Gros FX, Penault-Llorca F, Formento P, Cayre A, Dental C, Etienne-Grimaldi MC, Fischel JL, Milano G. Bozec A, et al. Among authors: penault llorca f. Eur J Cancer. 2008 Sep;44(13):1922-30. doi: 10.1016/j.ejca.2008.07.013. Epub 2008 Aug 6. Eur J Cancer. 2008. PMID: 18691881

10

[The use of breast cancer subtype classification to predict local and distant recurrence. A review].

Belkacémi Y, Penault-Llorca F, Gligorov J, Azria D. Belkacémi Y, et al. Among authors: penault llorca f. Cancer Radiother. 2008 Nov;12(6-7):577-83. doi: 10.1016/j.canrad.2008.08.272. Epub 2008 Sep 27. Cancer Radiother. 2008. PMID: 18824383 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters